Switzerland· 69469005

Desveneurax

A desvenlafaxine product containing desvenlafaxinum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC N06AX23

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedDesveneuraxATCN06AX23REGISTER NO.69469005PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Desvenlafaxine is registered in 5 of 19 countries.

Countries holding a registration under ATC N06AX23 (desvenlafaxine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 3 of them publish a price we can compare per daily dose

Desvenlafaxine · ATC N06AX23

5 / 19 countries

  • Canada
  • Germany
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of desvenlafaxine costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.41 in Spain to $0.82 in Switzerland — a ×2.0 gap.

  • Switzerland: $0.82 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Desvenlafaxine · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.82
  • ES Spain$0.41
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
desvenlafaxinum
Manufacturer
—
Country
Switzerland (CH)
ATC code
N06AX23
ATC class
Desvenlafaxine
Defined daily dose
50 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680694690058
    Blist 28 Stk
    CHF 40.25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

242 interactions on record for desvenlafaxine.

Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Desvenlafaxine · interactions on record

242 records

  • 25 severe
  • 196 moderate
  • 1 minor
  • 20 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Desvenlafaxine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All desvenlafaxine products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Austria · Desveneurax
  • Cyprus · Desvenlafaxine Adelco
  • Germany · Desveneurax, Desvenlafaxin Waymade
  • Spain · Desvenlafaxina Alter, Desvenlafaxina Cinfa
  • Greece · Desvenlafaxine Adelco
  • Italy · Faxilex
  • Malta · Desvenlafaxine Alembic, Desvenlafaxine Waymade
  • Portugal · Fasilex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da364162-eaa6-4a07-81ad-c584b0616388
GET /v1/drugs/da364162-eaa6-4a07-81ad-c584b0616388?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "desvenlafaxinum 100 mg",
  "valid_from": "2025-09-01",
  "limitations": null,
  "galenic_form": "Ret Tabl 100 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2025-09-01",
  "self_retention_pct": 10
}

See everything about desvenlafaxine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.